(Q34255316)

31 July 2017

Cervical screening: a guideline for clinical practice in Ontario (English)

1 reference

31 July 2017

Joan Murphy

1

1 reference

31 July 2017

Erin B Kennedy

2

1 reference

31 July 2017

Sheila Dunn

3

1 reference

31 July 2017

C Meg McLachlin

4

1 reference

31 July 2017

Michael Fung Kee Fung

5

1 reference

31 July 2017

Danusia Gzik

6

1 reference

31 July 2017

Michael Shier

7

1 reference

31 July 2017

Lawrence Paszat

8

1 reference

31 July 2017

Ontario Cervical Screening Program

9

1 reference

31 July 2017

Program in Evidence-based Care

10

1 reference

31 July 2017

1 May 2012

1 reference

Journal of Obstetrics and Gynaecology Canada

31 July 2017

1 reference

31 July 2017

34

1 reference

31 July 2017

5

1 reference

31 July 2017

453-458

1 reference

Ontario cervical cancer screening clinical practice guidelines

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Cervical cytology testing in teens

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

The practice guidelines development cycle: a conceptual tool for practice guidelines development and implementation

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

AGREE II: Advancing guideline development, reporting, and evaluation in health care

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Human papillomavirus and Papanicolaou tests to screen for cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Rate of cervical cancer, severe intraepithelial neoplasia, and adenocarcinoma in situ in primary HPV DNA screening with cytology triage: randomised study within organised screening programme

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Human papillomavirus DNA versus Papanicolaou screening tests for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

HPV screening for cervical cancer in rural India

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

The cytological screening turned out effective also for adenocarcinoma: a population-based case-control study in Trento, Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Short term persistence of human papillomavirus and risk of cervical precancer and cancer: population based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

HPV testing in primary cervical screening: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Human papillomavirus infection in adolescents: a rational approach

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Screening for cervical cancer: will women accept less?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Correlates of intent to seek unnecessary pap tests among elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2935242-2

7 January 2021

10.1016/S1701-2163(16)35242-2

Identifiers

DOI

1 reference

31 July 2017

1 reference